You have 9 free searches left this month | for more free features.

adenocarcinoma of the prostate

Showing 26 - 50 of 8,290

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Risk Map Decision Support System (DSS).
  • +2 more
  • (no location specified)
Jan 25, 2023

Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)

Completed
  • Prostate Disease
  • +6 more
  • Self-Administered Nitrous Oxide
  • Oxygen
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 25, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)

Terminated
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Columbia, Missouri
    Truman VA Hospital
Feb 15, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Tampa (Sunphenon, Placebo)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Tampa, Florida
  • +1 more
Dec 19, 2022

Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Relugolix Pill
  • +2 more
  • (no location specified)
Dec 23, 2022

Prediction of Lymph Node Invasion for Prostate Adenocarcinoma

Recruiting
  • Adenocarcinoma of the Prostate
    • Brest, France
      CHRU Brest
    Jan 17, 2022

    Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise

    Recruiting
    • Localized Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Best Practice
    • +4 more
    • Seattle, Washington
    • +1 more
    Jan 9, 2023

    Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Stereotactic Ablative Body Radiation
    • (no location specified)
    Oct 26, 2022

    Prostate Cancer Trial in Baltimore (hypofractionation)

    Active, not recruiting
    • Prostate Cancer
    • hypofractionation
    • Baltimore, Maryland
      The Johns Hopkins University School of Medicne
    Mar 18, 2022

    Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Exercise Therapy
    • Los Angeles, California
    • +7 more
    Feb 20, 2023

    Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

    Active, not recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • Charlotte, North Carolina
      Levine Cancer Institute
    Jan 12, 2023

    Tumor Molecular Profiling in Patients With Prostate Cancer

    Completed
    • Prostate Cancer
    • Metastatic Prostate Adenocarcinoma
    • Tumor molecular profiling
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Oct 17, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

    Not yet recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • (no location specified)
    Feb 2, 2023

    Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)

    Recruiting
    • Prostate Adenocarcinoma
    • Integrated boost
    • Valence, DrĂ´me, France
    • +3 more
    Oct 26, 2022

    Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,

    Not yet recruiting
    • Oligometastatic Prostate Carcinoma
    • +3 more
    • Lutetium Lu-177 PNT2002
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Aug 15, 2022

    Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

    Terminated
    • Metastatic Prostate Adenocarcinoma
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Jul 18, 2022

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Laboratory Biomarker Analysis
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 19, 2022

    Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy Trial (using Indocyanine Green,

    Not yet recruiting
    • Prostate Cancer Adenocarcinoma
    • Erectile Dysfunction Following Radical Prostatectomy
    • using Indocyanine Green
    • Nerve-sparing robot-assisted laparoscopic radical prostatectomy
    • (no location specified)
    Jul 21, 2023

    Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

    Recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Durvalumab
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 26, 2023

    Prostate Cancer, Prostate Adenocarcinoma Trial in Moscow (consequently performed 4 biopsy methods (TRUS-guided biopsy,

    Completed
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • consequently performed 4 biopsy methods (TRUS-guided biopsy, cognitive, fusion and transperineal template mapping biopsy)
    • Moscow, Russian Federation
      Institute for Urology and Reproductive Health, Sechenov Universi
    Oct 18, 2022

    Metastatic Castration-Resistant Prostate Adenocarcinoma Trial in United States (CCW702)

    Active, not recruiting
    • Metastatic Castration-Resistant Prostate Adenocarcinoma
    • San Diego, California
    • +4 more
    Sep 29, 2022

    Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

    Active, not recruiting
    • Metastatic Prostatic Adenocarcinoma
    • Charleston, South Carolina
      Medical University of South Carolina
    Jan 30, 2023

    Prostate Adenocarcinoma Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

    Recruiting
    • Prostate Adenocarcinoma
    • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • Haifa, Israel
    • +1 more
    Jul 4, 2022

    Quantitative HP MRI for Clinical Prostate Cancer Exam

    Active, not recruiting
    • Prostate Adenocarcinoma
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 16, 2022

    Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)

    Terminated
    • Prostate Cancer
    • Proton Beam Radiation Therapy
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 30, 2023